Oncology Early Phase / Multiple Disease Site Hematologic Malignancies Early Phase Team Plasma Cell Disorders Multiple Myeloma Relapsed/Refractory 2 or more prior lines
Categories
Protocols
GENMAB-GCT3014-01 Phase I/II OPEN TO ACCRUAL
An Open-Label, Multicenter, Phase 1/2 Trial of GEN3014 (HexaBody-CD38) in Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies